Turnstone Biologics
Matt Phillips has a diverse work experience in the field of biotechnology. Matt currently serves as a Principal Scientist in Translational Medicine at Turnstone Biologics. Prior to this, they worked at Instilbio as a Principal Scientist in Analytical Development, where they contributed to the planning and development of potency methods for product pipelines. Before that, they were a Senior Scientist in Analytical Development at Atara Biotherapeutics, where they developed a flow-based potency method for Tabelecleucel and led process characterization testing. Matt also has experience as a Senior Scientist and Lab Researcher at Advanced Diagnostics Lab/National Jewish Health, where they designed and improved clinical assays and managed pre-clinical projects for pharmaceutical companies. Matt started their career as a Postdoctoral Fellow at Kappler/Marrack Lab at National Jewish Health, where they worked on projects related to endogenous peptides and thymic Tregs.
Matt Phillips has a Bachelors of Science degree in Biology from Cornell University. Matt also attended the Cornell University Graduate School, where they obtained their Doctor of Philosophy (Ph.D.) degree in Pharmacology, with a minor in Biochemistry. The specific start and end years for their education are not provided.
This person is not in any offices
Turnstone Biologics
Turnstone Biologics, a privately held clinical stage biotech company, is developing breakthrough cancer immunotherapies by advancing two leading and complementary platforms that drive innate and adaptive tumor immunity, to provide benefit to the millions of cancer patients underserved by current treatment options.